NIBEC Co. Ltd - Asset Resilience Ratio

Latest as of March 2026: 2.47%

NIBEC Co. Ltd (138610) has an Asset Resilience Ratio of 2.47% as of March 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See NIBEC Co. Ltd current assets vs equity to evaluate short-term liquidity relative to the company's equity base.

Liquid Assets

₩1.57 Billion

≈ $1.06 Million USD Cash + Short-term Investments

Total Assets

₩63.61 Billion

≈ $43.10 Million USD All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio Trend (2016–2025)

This chart shows how NIBEC Co. Ltd's Asset Resilience Ratio has changed over time. For the complete balance sheet picture, see balance sheet size of NIBEC Co. Ltd.

Liquid Assets Composition Over Time

This chart breaks down NIBEC Co. Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. Explore NIBEC Co. Ltd (138610) long-term investment share to see how much of total assets are deployed in long-term investments.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	₩0.00	0%
Short-term Investments	₩1.57 Billion	2.47%
Total Liquid Assets	₩1.57 Billion	2.47%

Asset Resilience Insights

Limited Liquidity: NIBEC Co. Ltd maintains only 2.47% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company has significant short-term investments, indicating active treasury management.

NIBEC Co. Ltd Industry Peers by Asset Resilience Ratio

Compare NIBEC Co. Ltd's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
ALK-Abelló A/S CO:ALK-B	Biotechnology	0.98%
Mirum Pharmaceuticals Inc NASDAQ:MIRM	Biotechnology	6.89%
Xiamen Amoytop Biotech Co Ltd SHG:688278	Biotechnology	4.69%
BB Biotech AG SW:BION	Biotechnology	92.97%
Soleno Therapeutics Inc NASDAQ:SLNO	Biotechnology	20.15%
Nanobiotix NASDAQ:NBTX	Biotechnology	4.71%
Wuhan Keqian Biology Co Ltd SHG:688526	Biotechnology	19.42%
Beijing Konruns Pharmaceutical Co Ltd SHG:603590	Biotechnology	10.55%

Annual Asset Resilience Ratio for NIBEC Co. Ltd (2016–2025)

The table below shows the annual Asset Resilience Ratio data for NIBEC Co. Ltd.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2025-12-31	2.04%	₩1.29 Billion ≈ $872.33K	₩63.00 Billion ≈ $42.70 Million	+0.87pp
2024-12-31	1.17%	₩730.00 Million ≈ $494.71K	₩62.45 Billion ≈ $42.32 Million	-7.96pp
2023-12-31	9.13%	₩6.10 Billion ≈ $4.13 Million	₩66.80 Billion ≈ $45.27 Million	-2.53pp
2022-12-31	11.66%	₩8.77 Billion ≈ $5.94 Million	₩75.20 Billion ≈ $50.96 Million	+4.64pp
2021-12-31	7.02%	₩3.74 Billion ≈ $2.54 Million	₩53.28 Billion ≈ $36.11 Million	-43.62pp
2020-12-31	50.64%	₩26.88 Billion ≈ $18.22 Million	₩53.08 Billion ≈ $35.97 Million	+23.91pp
2019-12-31	26.74%	₩9.56 Billion ≈ $6.48 Million	₩35.73 Billion ≈ $24.22 Million	+22.89pp
2018-12-31	3.85%	₩858.97 Million ≈ $582.11K	₩22.32 Billion ≈ $15.12 Million	-16.64pp
2017-12-31	20.49%	₩5.28 Billion ≈ $3.58 Million	₩25.75 Billion ≈ $17.45 Million	+0.37pp
2016-12-31	20.13%	₩4.62 Billion ≈ $3.13 Million	₩22.97 Billion ≈ $15.57 Million	--

pp = percentage points

About NIBEC Co. Ltd

KQ:138610 Korea Biotechnology

Market Cap

$110.16 Million

₩162.56 Billion KRW

Market Cap Rank

#18919 Global

#896 in Korea

Share Price

₩14300.00

Change (1 day)

+1.27%

52-Week Range

₩12200.00 - ₩52300.00

All Time High

₩55200.00